000 | 01214 a2200337 4500 | ||
---|---|---|---|
005 | 20250518060115.0 | ||
264 | 0 | _c20191203 | |
008 | 201912s 0 0 eng d | ||
022 | _a1873-4294 | ||
024 | 7 |
_a10.2174/1568026619666190904163524 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHoo, Winfrey Pui Yee | |
245 | 0 | 0 |
_aOverview of Current Immunotherapies Targeting Mutated KRAS Cancers. _h[electronic resource] |
260 |
_bCurrent topics in medicinal chemistry _c2019 |
||
300 |
_a2158-2175 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntineoplastic Agents, Immunological _xpharmacology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImmunotherapy |
650 | 0 | 4 | _aMutation |
650 | 0 | 4 |
_aNeoplasms _xgenetics |
650 | 0 | 4 |
_aOncogene Protein p21(ras) _xantagonists & inhibitors |
650 | 0 | 4 | _aProto-Oncogene Mas |
650 | 0 | 4 |
_aT-Lymphocytes _ximmunology |
650 | 0 | 4 |
_aVaccines _ximmunology |
700 | 1 | _aSiak, Pui Yan | |
700 | 1 | _aIn, Lionel L A | |
773 | 0 |
_tCurrent topics in medicinal chemistry _gvol. 19 _gno. 23 _gp. 2158-2175 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.2174/1568026619666190904163524 _zAvailable from publisher's website |
999 |
_c30074836 _d30074836 |